Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panax Ginseng Augmentation in Schizophrenia
NCT00401089Phase 2Completed
- Start
- Dec 2002
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ginseng in schizophrenia. Started Dec 2002; status: completed.
02
Drugs
ginseng
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00401089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401089.